Page last updated: 2024-08-23

s-adenosylmethionine and Depressive Disorder, Treatment-Resistant

s-adenosylmethionine has been researched along with Depressive Disorder, Treatment-Resistant in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chedia, AM; Finegold, DN; McClain, LL; Pan, L; Peters, DG; Rengasamy, M; Sabol, R; Segretti, AM; Shaw, P1
Ferrucci, L; Gould, TD; Kadriu, B; Khadeer, M; Lovett, J; Moaddel, R; Morris, PJ; Ravichandran, S; Shardell, M; Thomas, CJ; Yuan, P; Zarate, CA1
Bottiglieri, T; Cassiello, C; Fava, M; Papakostas, GI; Roffman, J; Shelton, RC; Stahl, SM; Zajecka, JM1
Cassiello, CF; Iovieno, N; Papakostas, GI1

Reviews

1 review(s) available for s-adenosylmethionine and Depressive Disorder, Treatment-Resistant

ArticleYear
Folates and S-adenosylmethionine for major depressive disorder.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2012, Volume: 57, Issue:7

    Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Therapy, Combination; Evidence-Based Medicine; Humans; One-Carbon Group Transferases; Pteroylpolyglutamic Acids; Randomized Controlled Trials as Topic; S-Adenosylmethionine; Tetrahydrofolates

2012

Trials

2 trial(s) available for s-adenosylmethionine and Depressive Disorder, Treatment-Resistant

ArticleYear
Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects.
    Psychopharmacology, 2018, Volume: 235, Issue:10

    Topics: Adult; Amino Acids, Essential; Antidepressive Agents; Biogenic Amines; Carnitine; Cross-Over Studies; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Female; Glycerophospholipids; Humans; Ketamine; Lipids; Male; Metabolomics; Middle Aged; Sphingolipids; Young Adult

2018
Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial.
    The Journal of clinical psychiatry, 2014, Volume: 75, Issue:8

    Topics: Adolescent; Adult; Aged; Aldehydes; Biomarkers; C-Reactive Protein; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Female; Genotype; Humans; Male; Middle Aged; S-Adenosylhomocysteine; S-Adenosylmethionine; Selective Serotonin Reuptake Inhibitors; Tetrahydrofolates; Young Adult

2014

Other Studies

1 other study(ies) available for s-adenosylmethionine and Depressive Disorder, Treatment-Resistant

ArticleYear
Rare variants and biological pathways identified in treatment-refractory depression.
    Journal of neuroscience research, 2020, Volume: 98, Issue:7

    Topics: Adolescent; Adult; Alleles; Biopterins; Carnitine; Computer Simulation; Depressive Disorder, Treatment-Resistant; Exome Sequencing; Female; Genetic Predisposition to Disease; Humans; Male; Phenotype; Polymorphism, Single Nucleotide; Tetrahydrofolates; Young Adult

2020